[Prognostic value of high-risk cytogenetic abnormalities inmultiple myeloma] [0.03%]
多发性骨髓瘤患者高危细胞遗传学异常的预后价值分析
X X Shen,J P Yu,R Guo et al.
X X Shen et al.
To retrospectively analyze the clinical data of 465 newly diagnosed patients with multiple myeloma (NDMM) admitted to the First Affiliated Hospital of Nanjing Medical University from December 2016 to December 2024, and compare the prognosti...
[Analysis of peripheral blood monocyte subsets in chronic myelomonocytic leukemia: a single-center study] [0.03%]
慢性粒单细胞白血病患者外周血单核细胞亚群分析：单中心研究
L Wang,M M Li,J J Bai et al.
L Wang et al.
Objective: To evaluate the clinical value of peripheral blood monocyte subset analysis in the diagnosis and treatment of chronic myelomonocytic leukemia (CMML) . Method: We retrospectively enrolled 51 patients newly diagnosed with CMML at G...
[Clinical and molecular characteristics of myeloproliferative neoplasms patients with NFE2 gene mutations] [0.03%]
[NFE2基因突变的骨髓增殖性肿瘤临床及分子特征分析]
S Y Zhao,B Li,Z F Xu et al.
S Y Zhao et al.
Objective: To explore the clinical features and molecular characteristics of myeloproliferative neoplasms (MPNs) patients with NFE2 gene mutations. Methods: Gene targeted sequencing was used to detect NFE2 gene mutation in 723 patients diag...
[A preliminary analysis of the efficacy and safety of homoharringtonine, venetoclax, and azacitidine for newly diagnosed acute myeloid leukemia] [0.03%]
[海曲泊帕、维奈克拉及阿扎胞苷联合治疗新诊断急性髓系白血病的疗效和安全性初步分析]
H Ai,Q Wang,H F Wu et al.
H Ai et al.
Objective: To compare the efficacy and safety of two induction regimens, homoharringtonine plus venetoclax and azacitidine (VHA) versus venetoclax and azacitidine (VA) , for newly diagnosed acute myeloid leukemia (AML) patients who are elde...
[Incidence and associated factors of tyrosine kinase inhibitor withdrawal syndrome and psychological issues in patients with chronic-phase chronic myeloid leukemia after therapy discontinuation] [0.03%]
慢性期慢性髓性白血病治疗停药后酪氨酸激酶抑制剂撤药综合征及心理问题的发生率和相关因素分析
M Y Yuan,Z R Li,X S Zhang et al.
M Y Yuan et al.
Objectives: To investigate the incidence of tyrosine kinase inhibitor (TKI) withdrawal syndrome and psychological issues, and their associated factors, in patients with chronic-phase chronic myeloid leukemia (CML-CP) after TKI discontinuati...
[CD34(+) selected donor hematopoietic stem cell infusion for poor graft function after allogeneic hematopoietic stem cell transplantation: a retrospective cohort study] [0.03%]
选择性输注供者CD34阳性造血干细胞预防allo-HSCT后移植物功能低下：回顾性队列研究
S Liu,Q Li,Z Y Liu et al.
S Liu et al.
Objective: To evaluate the efficacy of purified donor CD34 positive hematopoietic stem cell (CD34(+) cell) infusion in patients with poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: T...
[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation] [0.03%]
急性髓系白血病haplo-HSCT患者aGVHD的危险因素分析
D Feng,W Liang,J X Cao et al.
D Feng et al.
Objective: To identify the risk factors for acute graft-versus-host disease (aGVHD) in patients with acute myeloid leukemia (AML) undergoing haploidentical hematopoietic stem cell transplantation (HID-HSCT) . Methods: A total of 141 AML pat...
[Methodological appraisal of statistical approaches to evaluating the impact of chronic graft-versus-host disease on mortality after hematopoietic stem cell transplantation] [0.03%]
评估统计学方法评价造血干细胞移植后慢性移植物抗宿主病对死亡影响的系统性回顾和 meta 分析：方法学评价
J J Wu,J F Wang
J J Wu
Objective: Using the impact of chronic graft-versus-host disease (cGVHD) on overall survival after hematopoietic stem cell transplantation as an example, this study aims to introduces and critically appraises five statistical approaches for...
[Chinese expert consensus on the clinical interpretation of donor-specific anti-HLA antibody test results in HLA-mismatched hematopoietic stem cell transplantation (2025)] [0.03%]
中国HLA mismatch造血干细胞移植供者特异性抗HLA抗体临床意义专家共识（2025）
Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association
Hematopoietic Stem Cell Application Group
Donor-specific anti-HLA antibodies (DSA)-induced primary graft failure remains a significant cause of mortality in patients undergoing HLA-mismatched allogeneic hematopoietic stem cell transplantation. In recent years, significant advances ...
[Chinese expert consensus on quality control, result analysis, and reporting of anti-HLA antibody testing in allogeneic hematopoietic stem cell transplantation (2025)] [0.03%]
中国allo-HSCT供者筛选HLA抗体检测质量控制、结果分析与报告专家共识(2025)
Experimental Diagnostics Group, Chinese Society of Hematology, Chinese Medical Association
Experimental Diagnostics Group
Antibodies against human leukocyte antigens (HLA) are closely related to engraftment, hematopoietic reconstitution, graft-versus-host disease, and are crucial for guiding treatment strategies and prognostic assessment in allogeneic hematopo...